Central Asia: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Central Asia

In 2022, the Central Asian market for other medicaments for therapeutic or prophylactic uses decreased by X% to $X, falling for the second year in a row after three years of growth. In general, consumption, however, saw a strong increase. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Central Asia

In value terms, production of other medicaments for therapeutic or prophylactic uses rose modestly to $X in 2022 estimated in export price. Over the period under review, production, however, enjoyed a strong increase. The growth pace was the most rapid in 2019 when the production volume increased by X% against the previous year. Over the period under review, production of attained the maximum level at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in Central Asia

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses was finally on the rise to reach X tons after two years of decline. In general, exports, however, continue to indicate a abrupt descent. The volume of export peaked at X tons in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. Over the period under review, exports, however, recorded a abrupt setback. Over the period under review, the exports of hit record highs at $X in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

Exports by Country

Uzbekistan prevails in uses structure, amounting to X tons, which was approx. X% of total exports in 2022. It was distantly followed by Kazakhstan (X kg), committing a X% share of total exports.

Uzbekistan was also the fastest-growing in terms of the other medicaments for therapeutic or prophylactic uses exports, with a CAGR of X% from 2012 to 2022. Kazakhstan (X%) illustrated a downward trend over the same period. While the share of Uzbekistan (X p.p.) increased significantly in terms of the total exports from 2012-2022, the share of Kazakhstan (X p.p.) displayed negative dynamics.

In value terms, Uzbekistan ($X) emerged as the largest other medicaments for therapeutic or prophylactic uses supplier in Central Asia, comprising X% of total exports. The second position in the ranking was taken by Kazakhstan ($X), with a X% share of total exports.

In Uzbekistan, exports of other medicaments for therapeutic or prophylactic uses expanded at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in Central Asia amounted to $X per ton, shrinking by X% against the previous year. In general, the export price, however, recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2016 an increase of X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2017 to 2022, the export prices failed to regain momentum.

Average prices varied somewhat amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Kazakhstan ($X per ton), while Uzbekistan amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kazakhstan (X%).

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in Central Asia

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the third year in a row after two years of growth. Overall, imports continue to indicate a pronounced contraction. The growth pace was the most rapid in 2018 when imports increased by X% against the previous year. The volume of import peaked at X tons in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses fell dramatically to $X in 2022. In general, imports, however, recorded a strong increase. The growth pace was the most rapid in 2018 with an increase of X%. The level of import peaked at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

Kazakhstan prevails in uses structure, amounting to X tons, which was approx. X% of total imports in 2022. Uzbekistan (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Tajikistan (X%). Turkmenistan (X tons) and Mongolia (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to other medicaments for therapeutic or prophylactic uses imports into Kazakhstan stood at X%. At the same time, Uzbekistan (X%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing importer imported in Central Asia, with a CAGR of X% from 2012-2022. By contrast, Tajikistan (X%), Mongolia (X%) and Turkmenistan (X%) illustrated a downward trend over the same period. Kazakhstan (X p.p.) and Uzbekistan (X p.p.) significantly strengthened its position in terms of the total imports, while Mongolia, Tajikistan and Turkmenistan saw its share reduced by X%, X% and X% from 2012 to 2022, respectively.

In value terms, Kazakhstan ($X) constitutes the largest market for imported other medicaments for therapeutic or prophylactic uses in Central Asia, comprising X% of total imports. The second position in the ranking was taken by Uzbekistan ($X), with a X% share of total imports. It was followed by Turkmenistan, with a X% share.

From 2012 to 2022, the average annual growth rate of value in Kazakhstan stood at X%. The remaining importing countries recorded the following average annual rates of imports growth: Uzbekistan (X% per year) and Turkmenistan (X% per year).

Import Prices by Country

In 2022, the import price in Central Asia amounted to $X per ton, falling by X% against the previous year. Over the period under review, the import price, however, saw a buoyant expansion. The pace of growth was the most pronounced in 2019 when the import price increased by X%. The level of import peaked at $X per ton in 2020; however, from 2021 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Kazakhstan ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kazakhstan (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :